SYS | | c009016 |
LBL | | ^^^^^nam^^22^^^^^^^^450^ |
005 | | 20010820105536.0 |
010 | | $a 0-88167-937-2 |
100 | | $a 19940913d1992 u y0sloc0103 ba |
101 | 0- | $a eng |
102 | | $a US |
105 | | $a a z 000yy |
200 | 1- | $a Cardiovascular toxicology $f edit. Daniel Acosta jr. |
205 | | $a 2nd ed. |
210 | | $a New York $c Raven Press $d 1992 |
215 | | $a ix, 560 s. $c il. |
225 | 2- | $a Target organ toxicology series |
410 | -1 | $1 001 sllk_un_auth*e001211 $1 500 10 $a Target organ toxicology series |
541 | 1- | $a Kardiovaskulárna toxikológia $z slo |
606 | | $a choroby kardiovaskulárne $x chemicky indukované $2 mesh $3 sllk_un_auth*d002318 |
606 | | $a systém kardiovaskulárny $x účinky liekov $2 mesh $3 sllk_un_auth*d002319 |
606 | | $a monitorovanie fyziologické $2 mesh $3 sllk_un_auth*d008991 |
606 | | $a bunky $2 mesh $3 sllk_un_auth*d002477 |
606 | | $a ischémia $2 mesh $3 sllk_un_auth*d007511 |
606 | | $3 sllk_un_auth*d000970 $a antineoplastiká $x účinky nežiaduce $2 mesh |
606 | | $a antibiotiká $x účinky nežiaduce $2 mesh $3 sllk_un_auth*d000900 |
606 | | $a katecholamíny $2 mesh $3 sllk_un_auth*d002395 |
606 | | $a srdce $x fyziológia $2 mesh $3 sllk_un_auth*d006321 |
606 | | $a fajčenie $2 mesh $3 sllk_un_auth*d012907 |
606 | | $a pitie alkoholu $2 mesh $3 sllk_un_auth*d000428 |
606 | | $a choroby cievne $x chemicky indukované $2 mesh $3 sllk_un_auth*d014652 |
606 | | $a cievy krvné $x účinky liekov $2 mesh $3 sllk_un_auth*d001808 |
675 | | $a 616.12:615.9 $v 1. stred. $z slo |
702 | -1 | $a Acosta $b Daniel $c jr. $3 sllk_un_auth*p0013488 $4 340 |
710 | 02 | $3 sllk_un_auth*k0000343 $a Cardiovascular and Interventional Radiological Society of Europe $4 070 |
712 | 02 | $3 sllk_un_auth*k0000344 $a Japanese Society of Angiography and Interventional Radiology $4 070 |
801 | -0 | $a SK $b BA006 $c 19981223 $g AACR2 |